Are you Dr. Fessler?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 57 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Department of Veterans Affairs Medical Center
508 Fulton St
Durham, NC 27705Phone+1 919-286-0411
Summary
- Dr. Michael Fessler, MD is a pulmonologist in Durham, North Carolina. He is currently licensed to practice medicine in North Carolina and Colorado. He is affiliated with Durham Veterans Affairs Medical Center.
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1999 - 2002
- Massachusetts General HospitalResidency, Internal Medicine, 1996 - 1999
- Harvard Medical SchoolClass of 1996
Certifications & Licensure
- NC State Medical License 2006 - 2025
- CO State Medical License 2000 - 2007
Clinical Trials
- Immune Cell Response to Stimuli Start of enrollment: 2009 Jul 13
- Study of the Effect of Innate on the Inflammatory Response to Endotoxin Start of enrollment: 2012 Jul 30
Publications & Presentations
PubMed
- 47 citationsCholesterol 25-hydroxylase promotes efferocytosis and resolution of lung inflammationJennifer H. Madenspacher, Eric D. Morrell, Kymberly M Gowdy, Jeffrey G. McDonald, Bonne M. Thompson
JCI Insight. 2020-06-04 - 22 citationsExtremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress SyndromeJerry A. Nick, Silvia M. Caceres, Jennifer E. Kret, Katie R. Poch, Matthew Strand
Plos One. 2016-09-08 - 19 citationsDifferential Tandem Mass Spectrometry-Based Cross-Linker: A New Approach for High Confidence in Identifying Protein Cross-Linking.Jayanta K. Chakrabarty, Aishwarya G. Naik, Michael B. Fessler, Gerhard R. Munske, Saiful M. Chowdhury
Analytical Chemistry. 2016-09-28
Press Mentions
- UDP-Glucose and P2Y14 Receptor Amplify Allergen-Induced Airway EosinophiliaApril 1st, 2021
- New Drugs Aim to Disarm the Immune System’s ‘Atomic Bomb’ CellsMarch 5th, 2020
- Fessler Wins First NIEHS Intramural Research AwardNovember 30th, 2016
Grant Support
- Cell Signaling Of Host DefenseNational Institute Of Environmental Health Sciences2009–2011
- Cell Signaling Of Host DefenseNational Institute Of Environmental Health Sciences2006–2008